RELIV INTERNATIONAL INC
DelistedCIK 768710fmd_12YFXSW8R37S28XZNV63BRVVH5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2020, 42 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 79 | 74 | 69 | 68 | 57 | 52 | 46 | 42 | 36 | 35 |
| Cost of revenue | 16 | 15 | 14 | 14 | 12 | 11 | 10 | 9 | 10 | 10 |
| Gross profit | 63 | 59 | 55 | 54 | 46 | 41 | 35 | 32 | 26 | 25 |
| Research and development | – | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Selling, general and administrative | 0 | – | – | – | – | – | 20 | 18 | 17 | 15 |
| Operating income | 3 | 2 | 2 | 2 | 0 | (1) | (1) | (0) | (2) | (1) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | 0 | 0 | (0) | (0) | (0) | 0 | 0 | 0 | 0 |
| Income before taxes | 3 | 2 | 2 | 1 | (0) | (1) | (1) | (0) | (2) | 0 |
| Income tax expense | 1 | 1 | 1 | 1 | (1) | (0) | 0 | 1 | 0 | 0 |
| Net income from continuing operations | 2 | 1 | 1 | 1 | 1 | (1) | (1) | (1) | (2) | (0) |
| Net income | 2 | 1 | 1 | 1 | 1 | (1) | (1) | (1) | (2) | (0) |